Gene: Procr (protein C receptor) Rattus norvegicus
Analyze
Symbol:
Procr
Name:
protein C receptor
Description:
Predicted to have signaling receptor activity. Predicted to be involved in negative regulation of coagulation. Localizes to the extracellular space and perinuclear region of cytoplasm. Biomarker of acute kidney failure and carotid stenosis. Orthologous to human PROCR (protein C receptor); PARTICIPATES IN protease mediated signaling via protease-activated receptor 1; protein C anticoagulant pathway; INTERACTS WITH (+)-schisandrin B; (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; 3,3',5,5'-tetrabromobisphenol A.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
activated protein C receptor; APC receptor; endothelial cell protein C receptor; endothelial protein C receptor; EPCR; LOC362248; MGC114418; MGC116255; protein C receptor, endothelial
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
PROCR (protein C receptor) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB
Mus musculus (house mouse):
Procr (protein C receptor, endothelial) HGNC
EggNOG, NCBI, OMA, HomoloGene, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Procr (protein C receptor) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
PROCR (protein C receptor) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
PROCR (protein C receptor) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Procr (protein C receptor) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
PROCR (protein C receptor) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
PROCR (protein C receptor)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Mus musculus (house mouse):
Procr (protein C receptor, endothelial)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
NCBI Annotation Information:
Annotation category: suggests misassembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 3 151,285,321 - 151,289,581 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_5.0 3 157,650,408 - 157,654,716 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 146,268,567 - 146,273,718 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 3 146,174,188 - 146,179,297 (+) NCBI Celera 3 142,978,809 - 142,983,065 (+) NCBI Celera Cytogenetic Map 3 q42 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Disease Annotations
Imported Annotations - ClinVar
long QT syndrome ISO RGD:1314349 8554872 ClinVar Annotator: match by term: Long QT syndrome ClinVar PMID:28492532
Imported Annotations - CTD
coronary artery disease ISO RGD:1314349 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:28530674 Experimental Liver Cirrhosis ISO RGD:1314349 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:25380136 Inflammation ISO RGD:1314349 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:23774263
(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PROCR mRNA] CTD PMID:31150632 (R)-rosmarinic acid multiple interactions ISO RGD:1314349 6480464 [rosmarinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ADAM17 protein]] which affects the localization of PROCR protein more ... CTD PMID:23774263 (R)-rosmarinic acid affects localization ISO RGD:1314350 6480464 rosmarinic acid affects the localization of PROCR protein CTD PMID:23774263 (R)-rosmarinic acid multiple interactions ISO RGD:1314350 6480464 rosmarinic acid results in decreased cleavage of and results in decreased secretion of PROCR protein CTD PMID:23774263 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PROCR mRNA CTD PMID:25729387 17alpha-ethynylestradiol decreases expression ISO RGD:1314350 6480464 Ethinyl Estradiol results in decreased expression of PROCR mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:1314349 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PROCR mRNA CTD PMID:19619570 17beta-estradiol affects expression ISO RGD:1314350 6480464 Estradiol affects the expression of PROCR mRNA CTD PMID:15598610 17beta-estradiol increases expression ISO RGD:1314349 6480464 Estradiol results in increased expression of PROCR mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314349 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PROCR mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314350 6480464 Tetrachlorodibenzodioxin affects the expression of PROCR mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314349 6480464 Tetrachlorodibenzodioxin results in increased expression of PROCR mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314349 6480464 Tetrachlorodibenzodioxin results in decreased expression of PROCR mRNA CTD PMID:19619570 2-tert-butylhydroquinone increases expression ISO RGD:1314350 6480464 2-tert-butylhydroquinone results in increased expression of PROCR mRNA CTD PMID:16014739 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1314350 6480464 tetrabromobisphenol A results in increased expression of PROCR mRNA CTD PMID:25172293 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of PROCR mRNA CTD PMID:28300664 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1314349 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PROCR mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PROCR mRNA CTD PMID:25380136 4-hydroxynon-2-enal increases expression ISO RGD:1314350 6480464 4-hydroxy-2-nonenal results in increased expression of PROCR mRNA CTD PMID:19191707 5-fluorouracil multiple interactions ISO RGD:1314349 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of PROCR mRNA] CTD PMID:15016801 7,12-dimethyltetraphene increases expression ISO RGD:1314349 6480464 9 more ... CTD PMID:21527772 actinomycin D increases expression ISO RGD:1314349 6480464 Dactinomycin results in increased expression of PROCR mRNA CTD PMID:21527772 aflatoxin B1 affects expression ISO RGD:1314349 6480464 Aflatoxin B1 affects the expression of PROCR protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1314349 6480464 Aflatoxin B1 results in increased expression of PROCR mRNA, Aflatoxin B1 results in increased expression of PROCR protein CTD PMID:21527772 more ... all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of PROCR mRNA CTD PMID:20488242 amphibole asbestos increases expression EXP 6480464 Asbestos, Amphibole results in increased expression of PROCR mRNA CTD PMID:22352330 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1314350 6480464 pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein] CTD PMID:24632454 antirheumatic drug decreases expression ISO RGD:1314349 6480464 Antirheumatic Agents results in decreased expression of PROCR mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1314349 6480464 Arsenic affects the methylation of PROCR gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1314349 6480464 Arsenic affects the methylation of PROCR gene CTD PMID:25304211 arsenic(3+) affects methylation ISO RGD:1314349 6480464 Arsenic affects the methylation of PROCR gene CTD PMID:25304211 benzo[a]pyrene increases expression ISO RGD:1314350 6480464 Benzo(a)pyrene results in increased expression of PROCR mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1314349 6480464 Benzo(a)pyrene results in increased expression of PROCR mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1314349 6480464 7 more ... CTD PMID:20382639 , PMID:26238291 benzo[b]fluoranthene increases expression ISO RGD:1314350 6480464 benzo(b)fluoranthene results in increased expression of PROCR mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO RGD:1314350 6480464 benzo(k)fluoranthene results in increased expression of PROCR mRNA CTD PMID:26377693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PROCR mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1314350 6480464 bisphenol A results in increased expression of PROCR mRNA CTD PMID:27623287 bisphenol A multiple interactions ISO RGD:1314349 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:1314349 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PROCR mRNA CTD PMID:28628672 butanal increases expression ISO RGD:1314349 6480464 butyraldehyde results in increased expression of PROCR mRNA CTD PMID:26079696 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of PROCR mRNA CTD PMID:22110744 cadmium dichloride decreases expression ISO RGD:1314349 6480464 Cadmium Chloride results in decreased expression of PROCR mRNA CTD PMID:26472689 carbon nanotube increases expression ISO RGD:1314350 6480464 Nanotubes, Carbon analog results in increased expression of PROCR mRNA, Nanotubes, Carbon results in increased expression of PROCR mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:1314350 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PROCR mRNA CTD PMID:20938992 cisplatin affects expression ISO RGD:1314349 6480464 Cisplatin affects the expression of PROCR mRNA CTD PMID:23300844 cisplatin multiple interactions ISO RGD:1314349 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PROCR mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1314349 6480464 Cisplatin results in increased expression of PROCR mRNA CTD PMID:27392435 copper(II) sulfate increases expression ISO RGD:1314349 6480464 Copper Sulfate results in increased expression of PROCR mRNA CTD PMID:19549813 cyclophosphamide increases expression ISO RGD:1314349 6480464 Cyclophosphamide results in increased expression of PROCR mRNA CTD PMID:21527772 cyclosporin A increases expression ISO RGD:1314349 6480464 Cyclosporine results in increased expression of PROCR mRNA CTD PMID:20106945 , PMID:21632981 dexamethasone increases expression ISO RGD:1314349 6480464 Dexamethasone results in increased expression of PROCR mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1314349 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PROCR mRNA CTD PMID:28628672 dibenz[a,h]anthracene increases expression ISO RGD:1314350 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PROCR mRNA CTD PMID:21266533 diclofenac increases expression ISO RGD:1314350 6480464 Diclofenac results in increased expression of PROCR mRNA CTD PMID:26934552 dicrotophos decreases expression ISO RGD:1314349 6480464 dicrotophos results in decreased expression of PROCR mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1314349 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1314349 6480464 Doxorubicin results in decreased expression of PROCR mRNA, Doxorubicin results in decreased expression of PROCR protein CTD PMID:17172434 doxorubicin multiple interactions ISO RGD:1314349 6480464 Doxorubicin results in increased metabolism of and results in increased secretion of PROCR protein, Glutathione inhibits the reaction [Doxorubicin results in decreased expression of PROCR protein] CTD PMID:17172434 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PROCR mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1314349 6480464 entinostat results in increased expression of PROCR mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1314349 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA CTD PMID:27188386 etoposide increases expression ISO RGD:1314349 6480464 Etoposide results in increased expression of PROCR mRNA CTD PMID:21527772 fluvastatin increases expression ISO RGD:1314349 6480464 fluvastatin results in increased expression of PROCR protein CTD PMID:16142594 folic acid multiple interactions ISO RGD:1314350 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PROCR mRNA CTD PMID:20938992 formaldehyde increases expression ISO RGD:1314349 6480464 Formaldehyde results in increased expression of PROCR mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of PROCR mRNA CTD PMID:27387713 glutathione multiple interactions ISO RGD:1314349 6480464 Glutathione inhibits the reaction [Doxorubicin results in decreased expression of PROCR protein] CTD PMID:17172434 hypochlorous acid increases expression ISO RGD:1314350 6480464 Hypochlorous Acid results in increased expression of PROCR mRNA CTD PMID:19376150 indometacin multiple interactions ISO RGD:1314349 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PROCR mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:1314350 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PROCR mRNA CTD PMID:20938992 lead diacetate increases expression ISO RGD:1314350 6480464 lead acetate results in increased expression of PROCR mRNA CTD PMID:20542052 lipopolysaccharide increases expression ISO RGD:1314350 6480464 Lipopolysaccharides results in increased expression of PROCR mRNA CTD PMID:27339419 methotrexate increases expression ISO RGD:1314349 6480464 Methotrexate results in increased expression of PROCR mRNA CTD PMID:17379860 methyl methacrylate increases expression ISO RGD:1314350 6480464 Methylmethacrylate results in increased expression of PROCR mRNA CTD PMID:16916219 methyl methanesulfonate increases expression ISO RGD:1314349 6480464 Methyl Methanesulfonate results in increased expression of PROCR mRNA CTD PMID:21527772 , PMID:23649840 Methylthiouracil multiple interactions ISO RGD:1314350 6480464 Methylthiouracil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PROCR protein modified form] CTD PMID:26298005 Methylthiouracil multiple interactions ISO RGD:1314349 6480464 Methylthiouracil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PROCR protein modified form] more ... CTD PMID:26298005 N-nitrosodiethylamine increases expression ISO RGD:1314349 6480464 Diethylnitrosamine results in increased expression of PROCR mRNA CTD PMID:21527772 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PROCR mRNA CTD PMID:25380136 nickel atom increases expression ISO RGD:1314349 6480464 Nickel results in increased expression of PROCR mRNA CTD PMID:24768652 , PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PROCR mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1314350 6480464 Acetaminophen affects the expression of PROCR mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1314350 6480464 Acetaminophen results in increased expression of PROCR mRNA CTD PMID:11264010 paraquat increases expression EXP 6480464 Paraquat results in increased expression of PROCR mRNA CTD PMID:20095324 paraquat multiple interactions EXP 6480464 Unithiol inhibits the reaction [Paraquat results in increased expression of PROCR mRNA] CTD PMID:20095324 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of PROCR mRNA CTD PMID:18158353 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1314349 6480464 [rosmarinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ADAM17 protein]] which affects the localization of PROCR protein more ... CTD PMID:23774263 more ... phorbol 13-acetate 12-myristate increases expression ISO RGD:1314349 6480464 Tetradecanoylphorbol Acetate results in increased expression of PROCR protein modified form CTD PMID:26298005 phorbol 13-acetate 12-myristate decreases cleavage ISO RGD:1314350 6480464 Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein CTD PMID:24632454 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1314350 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein] more ... CTD PMID:24632454 phorbol 13-acetate 12-myristate affects localization ISO RGD:1314349 6480464 Tetradecanoylphorbol Acetate affects the localization of PROCR protein CTD PMID:23774263 pirinixic acid multiple interactions ISO RGD:1314349 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PROCR mRNA CTD PMID:19710929 propanal increases expression ISO RGD:1314349 6480464 propionaldehyde results in increased expression of PROCR mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:1314349 6480464 Quercetin results in increased expression of PROCR mRNA CTD PMID:21632981 rosmarinic acid multiple interactions ISO RGD:1314349 6480464 [rosmarinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ADAM17 protein]] which affects the localization of PROCR protein more ... CTD PMID:23774263 rosmarinic acid multiple interactions ISO RGD:1314350 6480464 rosmarinic acid results in decreased cleavage of and results in decreased secretion of PROCR protein CTD PMID:23774263 rosmarinic acid affects localization ISO RGD:1314350 6480464 rosmarinic acid affects the localization of PROCR protein CTD PMID:23774263 SB 203580 multiple interactions ISO RGD:1314350 6480464 SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein] CTD PMID:24632454 SB 431542 multiple interactions ISO RGD:1314349 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide affects secretion ISO RGD:1314349 6480464 Silicon Dioxide analog affects the secretion of PROCR protein CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1314350 6480464 Silicon Dioxide results in increased expression of PROCR mRNA CTD PMID:19073995 , PMID:23221170 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of PROCR mRNA CTD PMID:25993096 sodium fluoride decreases expression ISO RGD:1314350 6480464 Sodium Fluoride results in decreased expression of PROCR protein CTD PMID:28918527 sodium fluoride increases expression ISO RGD:1314350 6480464 Sodium Fluoride results in increased expression of PROCR mRNA CTD PMID:27862939 Soman increases expression EXP 6480464 Soman results in increased expression of PROCR mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1314350 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PROCR mRNA CTD PMID:21641980 tetrachloromethane affects expression ISO RGD:1314350 6480464 Carbon Tetrachloride affects the expression of PROCR mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PROCR mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PROCR mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1314350 6480464 Carbon Tetrachloride results in increased expression of PROCR mRNA CTD PMID:27339419 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PROCR mRNA CTD PMID:23411599 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of PROCR mRNA CTD PMID:30012374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PROCR mRNA CTD PMID:25729387 troglitazone increases expression ISO RGD:1314350 6480464 troglitazone results in increased expression of PROCR mRNA CTD PMID:28973697 tunicamycin decreases expression ISO RGD:1314349 6480464 Tunicamycin results in decreased expression of PROCR mRNA CTD PMID:29453283 valproic acid affects expression ISO RGD:1314349 6480464 Valproic Acid affects the expression of PROCR mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1314349 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1314349 6480464 Valproic Acid results in increased expression of PROCR mRNA CTD PMID:23179753 more ... vorinostat increases expression ISO RGD:1314349 6480464 vorinostat results in increased expression of PROCR mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1314349 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:1314349 6480464 vorinostat results in decreased expression of PROCR mRNA CTD PMID:18769122 withaferin A multiple interactions ISO RGD:1314349 6480464 withaferin A inhibits the reaction [IL1B protein promotes the reaction [ADAM17 protein results in increased cleavage of PROCR protein]] more ... CTD PMID:24632454
Gene-Chemical Interaction Annotations
